Skip to main content
FinSpry Logo
FinSpry
CBIO logo
CBIO
(NASDAQ)
Crescent Biopharma, Inc.
$19.96-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Crescent Biopharma (CBIO) Stock Price & Financial Analysis

Crescent Biopharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$19.92 - $20.91
52-Week High$27.41
52-Week Low$8.72
Open$20.30
Volume292.36K
Average Volume (3M)257.78K
Market Cap609.42M
Shares Outstanding30.53M
Price to Sales (P/S)51.29
Price to Book (P/B)3.83
EV/EBITDA-2.65
Revenue (TTM)11.88M
Net Income (TTM)-165.12M
Free Cash Flow (TTM)-153.62M
EPS (TTM)$-6.76
Profit Margin-1389.58%
Operating Margin-1417.74%
Return on Equity (ROE)-103.70%
Debt to Equity0.01
50-Day MA$16.87
200-Day MA$15.53
52-Week Change59.04%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateJan 13, 2023

Frequently Asked Questions About Crescent Biopharma

What is the current stock price for CBIO?

As of the latest trading session, CBIO stock trades at $19.96. The 52-week range is $8.72–$27.41, with a day range of $19.92–$20.91.

What is the P/E ratio for CBIO?

The P/E ratio (Price-to-Earnings) for CBIO is shown in the Key Statistics section. This valuation metric helps compare Crescent Biopharma, Inc. to industry peers.

Does CBIO pay dividends?

Crescent Biopharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CBIO?

Based on 2 analysts, the consensus for CBIO is Buy.

What is the market cap of CBIO?

Crescent Biopharma's market capitalization is $609.4M, classifying it as a small-cap company. Crescent Biopharma operates in the Healthcare sector within the Biotechnology industry.